That's a significant decision, and it's completely understandable to want more information before feeling comfortable with it. The general thinking in myeloma care is that maintenance therapy helps keep the disease in remission for as long as possible — and research suggests it can become more effective the longer it's Show Full Answer
That's a significant decision, and it's completely understandable to want more information before feeling comfortable with it. The general thinking in myeloma care is that maintenance therapy helps keep the disease in remission for as long as possible — and research suggests it can become more effective the longer it's taken.
Many doctors recommend staying on maintenance therapy until there's no detectable myeloma (called MRD-negative status), as long as side effects are manageable. That said, every situation is different. Your doctor may be weighing factors like:
- Your current response to treatment
- How well you've been tolerating the therapy
- Your overall health and quality of life
- Whether you've achieved a deep remission
The balance between treatment benefits and side effects is always part of the conversation. It would be worth asking your doctor specifically what criteria led to this consideration, and whether achieving MRD-negative status played a role. Monitoring with bloodwork and bone marrow biopsies is a standard way to track myeloma activity, so you'd still be closely watched.
Don't hesitate to ask for a second opinion from another myeloma specialist if you're unsure — that's always a reasonable step with big treatment decisions.
August 14
Join
Your Privacy Choices
